 | • レポートコード：GIR201111119 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、遊離脂肪酸受容体4の世界市場を調査対象にし、遊離脂肪酸受容体4の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（CB-001、GSK-137647A、SC-410、その他）、用途別分析（非アルコール性脂肪性肝疾患、2型糖尿病、代謝性疾患、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Advinus Therapeutics Ltd、Dompe Farmaceutici SpA、AstraZeneca Plc、Sancilio & Company Inc、CymaBay Therapeutics Inc、Merck & Co Inc、GlaxoSmithKline Plc ・メーカー別販売量、売上、市場シェア ・遊離脂肪酸受容体4の地域別市場分析 ・遊離脂肪酸受容体4の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・遊離脂肪酸受容体4のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・遊離脂肪酸受容体4のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・遊離脂肪酸受容体4の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・遊離脂肪酸受容体4の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・遊離脂肪酸受容体4の種類別市場規模2015-2020：CB-001、GSK-137647A、SC-410、その他 ・遊離脂肪酸受容体4の用途別市場規模2015-2020：非アルコール性脂肪性肝疾患、2型糖尿病、代謝性疾患、その他 ・遊離脂肪酸受容体4の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Free Fatty Acid Receptor 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Free Fatty Acid Receptor 4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Free Fatty Acid Receptor 4 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Free Fatty Acid Receptor 4 market has been segmented into
CB-001
GSK-137647A
SC-410
Others
By Application, Free Fatty Acid Receptor 4 has been segmented into:
Non Alcoholic Fatty Liver Disease
Type 2 Diabets
Metabolic Disorders
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Free Fatty Acid Receptor 4 market presented in the report. This section sheds light on the sales growth of different regional and country-level Free Fatty Acid Receptor 4 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Free Fatty Acid Receptor 4 market.
The report offers in-depth assessment of the growth and other aspects of the Free Fatty Acid Receptor 4 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Free Fatty Acid Receptor 4 Market Share Analysis
Free Fatty Acid Receptor 4 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Free Fatty Acid Receptor 4 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Free Fatty Acid Receptor 4 sales, revenue and market share for each player covered in this report.
The major players covered in Free Fatty Acid Receptor 4 are:
Advinus Therapeutics Ltd
Dompe Farmaceutici SpA
AstraZeneca Plc
Sancilio & Company Inc
CymaBay Therapeutics Inc
Merck & Co Inc
GlaxoSmithKline Plc
Among other players domestic and global, Free Fatty Acid Receptor 4 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Free Fatty Acid Receptor 4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Free Fatty Acid Receptor 4, with price, sales, revenue and global market share of Free Fatty Acid Receptor 4 in 2018 and 2019.
Chapter 3, the Free Fatty Acid Receptor 4 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Free Fatty Acid Receptor 4 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Free Fatty Acid Receptor 4 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Free Fatty Acid Receptor 4 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Free Fatty Acid Receptor 4 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Free Fatty Acid Receptor 4 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CB-001
1.2.3 GSK-137647A
1.2.4 SC-410
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Free Fatty Acid Receptor 4 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Non Alcoholic Fatty Liver Disease
1.3.3 Type 2 Diabets
1.3.4 Metabolic Disorders
1.3.5 Others
1.4 Overview of Global Free Fatty Acid Receptor 4 Market
1.4.1 Global Free Fatty Acid Receptor 4 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Advinus Therapeutics Ltd
2.1.1 Advinus Therapeutics Ltd Details
2.1.2 Advinus Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advinus Therapeutics Ltd SWOT Analysis
2.1.4 Advinus Therapeutics Ltd Product and Services
2.1.5 Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dompe Farmaceutici SpA
2.2.1 Dompe Farmaceutici SpA Details
2.2.2 Dompe Farmaceutici SpA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dompe Farmaceutici SpA SWOT Analysis
2.2.4 Dompe Farmaceutici SpA Product and Services
2.2.5 Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca Plc
2.3.1 AstraZeneca Plc Details
2.3.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca Plc SWOT Analysis
2.3.4 AstraZeneca Plc Product and Services
2.3.5 AstraZeneca Plc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sancilio & Company Inc
2.4.1 Sancilio & Company Inc Details
2.4.2 Sancilio & Company Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sancilio & Company Inc SWOT Analysis
2.4.4 Sancilio & Company Inc Product and Services
2.4.5 Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 CymaBay Therapeutics Inc
2.5.1 CymaBay Therapeutics Inc Details
2.5.2 CymaBay Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CymaBay Therapeutics Inc SWOT Analysis
2.5.4 CymaBay Therapeutics Inc Product and Services
2.5.5 CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co Inc
2.6.1 Merck & Co Inc Details
2.6.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck & Co Inc SWOT Analysis
2.6.4 Merck & Co Inc Product and Services
2.6.5 Merck & Co Inc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline Plc
2.7.1 GlaxoSmithKline Plc Details
2.7.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline Plc SWOT Analysis
2.7.4 GlaxoSmithKline Plc Product and Services
2.7.5 GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Free Fatty Acid Receptor 4 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Free Fatty Acid Receptor 4 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Free Fatty Acid Receptor 4 Manufacturer Market Share in 2019
3.3.2 Top 6 Free Fatty Acid Receptor 4 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Free Fatty Acid Receptor 4 Sales, Revenue and Market Share by Regions
4.1.1 Global Free Fatty Acid Receptor 4 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Free Fatty Acid Receptor 4 Revenue and Market Share by Regions (2015-2020)
4.2 North America Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
4.3 Europe Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
4.5 South America Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Free Fatty Acid Receptor 4 Sales, Revenue and Market Share by Country
5.1.1 North America Free Fatty Acid Receptor 4 Sales and Market Share by Country (2015-2020)
5.1.2 North America Free Fatty Acid Receptor 4 Revenue and Market Share by Country (2015-2020)
5.2 United States Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
5.3 Canada Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
5.4 Mexico Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Free Fatty Acid Receptor 4 Sales, Revenue and Market Share by Country
6.1.1 Europe Free Fatty Acid Receptor 4 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Free Fatty Acid Receptor 4 Revenue and Market Share by Country (2015-2020)
6.2 Germany Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
6.3 UK Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
6.4 France Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
6.5 Russia Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
6.6 Italy Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Free Fatty Acid Receptor 4 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Free Fatty Acid Receptor 4 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Free Fatty Acid Receptor 4 Revenue and Market Share by Regions (2015-2020)
7.2 China Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
7.3 Japan Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
7.4 Korea Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
7.5 India Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
7.7 Australia Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Free Fatty Acid Receptor 4 Sales, Revenue and Market Share by Country
8.1.1 South America Free Fatty Acid Receptor 4 Sales and Market Share by Country (2015-2020)
8.1.2 South America Free Fatty Acid Receptor 4 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
8.3 Argentina Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Free Fatty Acid Receptor 4 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Free Fatty Acid Receptor 4 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Free Fatty Acid Receptor 4 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
9.3 Turkey Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
9.4 Egypt Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
9.5 South Africa Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Free Fatty Acid Receptor 4 Sales and Market Share by Type (2015-2020)
10.2 Global Free Fatty Acid Receptor 4 Revenue and Market Share by Type (2015-2020)
10.3 Global Free Fatty Acid Receptor 4 Price by Type (2015-2020)
11 Global Free Fatty Acid Receptor 4 Market Segment by Application
11.1 Global Free Fatty Acid Receptor 4 Sales Market Share by Application (2015-2020)
11.2 Global Free Fatty Acid Receptor 4 Revenue Market Share by Application (2015-2020)
11.3 Global Free Fatty Acid Receptor 4 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Free Fatty Acid Receptor 4 Sales, Revenue and Growth Rate (2021-2025)
12.2 Free Fatty Acid Receptor 4 Market Forecast by Regions (2021-2025)
12.2.1 North America Free Fatty Acid Receptor 4 Market Forecast (2021-2025)
12.2.2 Europe Free Fatty Acid Receptor 4 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Free Fatty Acid Receptor 4 Market Forecast (2021-2025)
12.2.4 South America Free Fatty Acid Receptor 4 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Free Fatty Acid Receptor 4 Market Forecast (2021-2025)
12.3 Free Fatty Acid Receptor 4 Market Forecast by Type (2021-2025)
12.3.1 Global Free Fatty Acid Receptor 4 Sales Forecast by Type (2021-2025)
12.3.2 Global Free Fatty Acid Receptor 4 Market Share Forecast by Type (2021-2025)
12.4 Free Fatty Acid Receptor 4 Market Forecast by Application (2021-2025)
12.4.1 Global Free Fatty Acid Receptor 4 Sales Forecast by Application (2021-2025)
12.4.2 Global Free Fatty Acid Receptor 4 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Free Fatty Acid Receptor 4 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Free Fatty Acid Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Free Fatty Acid Receptor 4 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Advinus Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Major Business
Table 9. Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 10. Advinus Therapeutics Ltd SWOT Analysis
Table 11. Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Product and Services
Table 12. Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Dompe Farmaceutici SpA Basic Information, Manufacturing Base and Competitors
Table 14. Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Major Business
Table 15. Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 16. Dompe Farmaceutici SpA SWOT Analysis
Table 17. Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Product and Services
Table 18. Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Plc Free Fatty Acid Receptor 4 Major Business
Table 21. AstraZeneca Plc Free Fatty Acid Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 22. AstraZeneca Plc SWOT Analysis
Table 23. AstraZeneca Plc Free Fatty Acid Receptor 4 Product and Services
Table 24. AstraZeneca Plc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sancilio & Company Inc Basic Information, Manufacturing Base and Competitors
Table 26. Sancilio & Company Inc Free Fatty Acid Receptor 4 Major Business
Table 27. Sancilio & Company Inc Free Fatty Acid Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 28. Sancilio & Company Inc SWOT Analysis
Table 29. Sancilio & Company Inc Free Fatty Acid Receptor 4 Product and Services
Table 30. Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. CymaBay Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Major Business
Table 33. CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 34. CymaBay Therapeutics Inc SWOT Analysis
Table 35. CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Product and Services
Table 36. CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 38. Merck & Co Inc Free Fatty Acid Receptor 4 Major Business
Table 39. Merck & Co Inc Free Fatty Acid Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 40. Merck & Co Inc SWOT Analysis
Table 41. Merck & Co Inc Free Fatty Acid Receptor 4 Product and Services
Table 42. Merck & Co Inc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Major Business
Table 45. GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Total Revenue (USD Million) (2018-2019)
Table 46. GlaxoSmithKline Plc SWOT Analysis
Table 47. GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Product and Services
Table 48. GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Free Fatty Acid Receptor 4 Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Free Fatty Acid Receptor 4 Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Free Fatty Acid Receptor 4 Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Free Fatty Acid Receptor 4 Sales Market Share by Regions (2015-2020)
Table 53. Global Free Fatty Acid Receptor 4 Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Free Fatty Acid Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Free Fatty Acid Receptor 4 Sales Market Share by Countries (2015-2020)
Table 56. North America Free Fatty Acid Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Free Fatty Acid Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 58. Europe Free Fatty Acid Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Free Fatty Acid Receptor 4 Sales Market Share by Countries (2015-2020)
Table 60. Europe Free Fatty Acid Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Free Fatty Acid Receptor 4 Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Free Fatty Acid Receptor 4 Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Free Fatty Acid Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Free Fatty Acid Receptor 4 Sales Market Share by Countries (2015-2020)
Table 66. South America Free Fatty Acid Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Free Fatty Acid Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Free Fatty Acid Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Free Fatty Acid Receptor 4 Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Free Fatty Acid Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Free Fatty Acid Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 72. Global Free Fatty Acid Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 73. Global Free Fatty Acid Receptor 4 Sales Share by Type (2015-2020)
Table 74. Global Free Fatty Acid Receptor 4 Revenue by Type (2015-2020) (USD Million)
Table 75. Global Free Fatty Acid Receptor 4 Revenue Share by Type (2015-2020)
Table 76. Global Free Fatty Acid Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 77. Global Free Fatty Acid Receptor 4 Sales Share by Application (2015-2020)
Table 78. Global Free Fatty Acid Receptor 4 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Free Fatty Acid Receptor 4 Market Share Forecast by Regions (2021-2025)
Table 80. Global Free Fatty Acid Receptor 4 Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Free Fatty Acid Receptor 4 Market Share Forecast by Type (2021-2025)
Table 82. Global Free Fatty Acid Receptor 4 Sales Forecast by Application (2021-2025)
Table 83. Global Free Fatty Acid Receptor 4 Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Free Fatty Acid Receptor 4 Picture
Figure 2. Global Sales Market Share of Free Fatty Acid Receptor 4 by Type in 2019
Figure 3. CB-001 Picture
Figure 4. GSK-137647A Picture
Figure 5. SC-410 Picture
Figure 6. Others Picture
Figure 7. Free Fatty Acid Receptor 4 Sales Market Share by Application in 2018
Figure 8. Non Alcoholic Fatty Liver Disease Picture
Figure 9. Type 2 Diabets Picture
Figure 10. Metabolic Disorders Picture
Figure 11. Others Picture
Figure 12. Global Free Fatty Acid Receptor 4 Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Free Fatty Acid Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Free Fatty Acid Receptor 4 Sales Market Share by Manufacturer in 2019
Figure 33. Global Free Fatty Acid Receptor 4 Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Free Fatty Acid Receptor 4 Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Free Fatty Acid Receptor 4 Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Free Fatty Acid Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Free Fatty Acid Receptor 4 Revenue Market Share by Regions (2015-2020)
Figure 40. Global Free Fatty Acid Receptor 4 Revenue Market Share by Regions in 2018
Figure 41. North America Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
Figure 42. Europe Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
Figure 44. South America Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020)
Figure 46. North America Free Fatty Acid Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Free Fatty Acid Receptor 4 Sales Market Share by Countries (2015-2020)
Figure 48. North America Free Fatty Acid Receptor 4 Sales Market Share by Countries in 2018
Figure 49. North America Free Fatty Acid Receptor 4 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Free Fatty Acid Receptor 4 Revenue Market Share by Countries in 2018
Figure 51. United States Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Free Fatty Acid Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Free Fatty Acid Receptor 4 Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Free Fatty Acid Receptor 4 Revenue Market Share by Countries in 2019
Figure 57. Germany Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Free Fatty Acid Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Free Fatty Acid Receptor 4 Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Free Fatty Acid Receptor 4 Revenue Market Share by Regions 2019
Figure 65. China Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Free Fatty Acid Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Free Fatty Acid Receptor 4 Sales Market Share by Countries in 2019
Figure 72. South America Free Fatty Acid Receptor 4 Revenue Market Share by Countries in 2019
Figure 73. Brazil Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Free Fatty Acid Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Free Fatty Acid Receptor 4 Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Free Fatty Acid Receptor 4 Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Free Fatty Acid Receptor 4 Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Free Fatty Acid Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Free Fatty Acid Receptor 4 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Free Fatty Acid Receptor 4 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Free Fatty Acid Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Free Fatty Acid Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Free Fatty Acid Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Free Fatty Acid Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Free Fatty Acid Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
トール油脂肪酸の世界市場 2020年 Market Overview The Tall Oil Fatty Acid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 脂肪酸サプリメントの世界市場 2020年 Market Overview The global Fatty Acid Supplements market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fatty Acid Supplements…
- 脂肪酸ポリグリセリンエステルの世界市場 2020年 Market Overview The Polyglycerol Esters of Fatty Acid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- レチノイン酸受容体ベータの世界市場 2020年 Market Overview The global Retinoic Acid Receptor Beta market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinoic Acid Rec…
- 必須脂肪酸の世界市場 2020年 Market Overview The global Essential Fatty Acids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.6% in the forecast period of 2020 to 2025 and will expected to reach USD 5429.6 million by 2025, from USD 4051.1 million in 2019. The Essential Fatt…